- Home
- PMTS vs CADL Comparison
PMTS vs CADL Comparison
Compare PMTS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- CADL
- Stock Information
- Founded
- PMTS 2007
- CADL 1999
- Country
- PMTS United States
- CADL United States
- Employees
- PMTS N/A
- CADL N/A
- Industry
- PMTS Finance Companies
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- CADL Health Care
- Exchange
- PMTS Nasdaq
- CADL Nasdaq
- Market Cap
- PMTS 316.9M
- CADL 306.4M
- IPO Year
- PMTS 2015
- CADL 2021
- Fundamental
- Price
- PMTS $29.40
- CADL $8.06
- Analyst Decision
- PMTS Strong Buy
- CADL Strong Buy
- Analyst Count
- PMTS 4
- CADL 4
- Target Price
- PMTS $37.25
- CADL $21.00
- AVG Volume (30 Days)
- PMTS 36.7K
- CADL 1.2M
- Earning Date
- PMTS 03-04-2025
- CADL 03-13-2025
- Dividend Yield
- PMTS N/A
- CADL N/A
- EPS Growth
- PMTS N/A
- CADL N/A
- EPS
- PMTS 1.64
- CADL N/A
- Revenue
- PMTS $480,601,000.00
- CADL N/A
- Revenue This Year
- PMTS $8.62
- CADL N/A
- Revenue Next Year
- PMTS $7.15
- CADL N/A
- P/E Ratio
- PMTS $17.86
- CADL N/A
- Revenue Growth
- PMTS 8.11
- CADL N/A
- 52 Week Low
- PMTS $15.21
- CADL $1.40
- 52 Week High
- PMTS $35.19
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- PMTS 49.90
- CADL 45.77
- Support Level
- PMTS $27.90
- CADL $8.33
- Resistance Level
- PMTS $29.69
- CADL $9.08
- Average True Range (ATR)
- PMTS 1.85
- CADL 0.59
- MACD
- PMTS 0.00
- CADL -0.04
- Stochastic Oscillator
- PMTS 34.93
- CADL 42.70
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.